News about Market

CLINUVEL Grows Singapore RD&I Hub to Advance Peptide Innovation

CLINUVEL is expanding its VALLAURIX Research, Development & Innovation Centre in Singapore to strengthen its work on next-generation peptide therapies. The five-year, EDB-supported investment will enhance facilities, accelerate development of liquid long-acting drug delivery platforms, and allow RD&I teams to advance late-stage programmes.

Market | 08/12/2025 | By Dineshwori |  139

Viatris to Receive USD 400 Million in Cash and USD 415 Million in Equity Shares of Biocon

Viatris is set to receive USD 400 million in cash and USD 415 million in Biocon equity shares as part of a revised agreement, accelerating the end of non-compete restrictions in the biosimilars space and enabling both companies to pursue expanded market opportunities.

Market | 08/12/2025 | By Dineshwori |  114

Virax Biolabs Closes USD 5 Million Private Placement

Virax Biolabs has closed a USD 5 million private placement, extending its cash runway into the first half of 2028 and supporting ongoing regulatory studies for its ViraxImmune platform, including long COVID and post-acute infection syndrome programmes, alongside planned FDA and MHRA submissions and platform expansion initiatives.

Market | 06/12/2025 | By Dineshwori |  239

Sanofi Completes Vicebio Takeover

This acquisition brings an early-stage combination vaccine candidate for respiratory syncytial virus (RSV) and human metapneumovirus (HMPV), both respiratory viruses, and expands the capabilities in vaccine design and development with Vicebio’s ‘Molecular Clamp’ technology.

Market | 05/12/2025 | By Darshana |  147

Lupin and Valorum Enter into Licensing Agreement for Armlupeg in US

Under the terms of the agreement, Valorum will advance the commercialisation and distribution of Armlupeg (pegfilgrastim-unne) in the US. Lupin will be responsible for manufacturing and supply of the product and will receive an upfront licence fee and a royalty payment on net sales.

Market | 05/12/2025 | By Dineshwori |  133

Aptar Acquires Sommaplast, Provider of Oral Dosing Pharma Packaging Solutions

The acquisition of Sommaplast strengthens Aptar’s pharmaceutical portfolio and expands its footprint in Latin America, giving the company access to Sommaplast’s established expertise in oral dosing components and its growing customer base across Brazil’s healthcare market.

Market | 04/12/2025 | By Dineshwori |  164

Philips Unveils World's First Helium-free 3.0T MRI Platform

Philips has introduced the world’s first helium-free 3.0T MRI platform, the BlueSeal Horizon, marking a significant technological milestone in medical imaging. The new system combines a fully sealed, helium-independent magnet with advanced AI tools to deliver faster workflows, improved sustainability, and enhanced clinical insights.

Market | 04/12/2025 | By Dineshwori |  334

Syntegon Makes Spare Parts Sourcing Easier with Mysyntegon Webshop

Syntegon has introduced a new digital platform, the mySyntegon webshop, designed to simplify machine spare-parts sourcing and ordering through AI-driven image recognition.

Market | 04/12/2025 | By Dineshwori |  159

Cipla Partners with Stempeutics, Launches Stem Cell Therapy for Knee Osteoarthritis

Cipla has partnered with Stempeutics to launch Ciplostem, a single-dose stem cell therapy for knee osteoarthritis. The treatment uses 25 million expanded Bone Marrow–derived Mesenchymal Stem Cells (BM-MSCs) combined with hyaluronic acid to support joint repair and pain relief.

Market | 04/12/2025 | By Dineshwori |  187

Sun Pharma Announces Major INR 3,000 Crore Expansion in MP

Sun Pharmaceutical Industries’ wholly owned subsidiary, Sun Pharma Laboratories Ltd, has approved an investment of INR 3,000 crore to set up a new greenfield formulations manufacturing facility in Madhya Pradesh.

Market | 04/12/2025 | By Darshana |  507